Ruxandra Draghia-Akli, EVP, Research & Development: Novavax NVAX Planned sale · Filed 05/27

Trade details

Type: Planned sale notice
Stock: Novavax NVAX
Person: Ruxandra Draghia-AkliEVP, Research & Development
Planned sale date: 26/05/27
Filed: 26/05/27

More to sell after $296.1K in 3 months

Novavax trades, last 26 weeks

What else happened in Novavax around then

Filed or reported within 30 days of the trade day · 04/27~06/26

Ruxandra Draghia-Akli's recent trades

Ruxandra Draghia-AkliEVP, Research & Development
Planned saleNovavax
Planned sale
Novavax
NVAX
$296.1K
30,000 sh
$296.1K
Filed 05/07
Traded 05/07

Ruxandra Draghia-Akli, EVP — plans to sell 21,383 sh of Novavax NVAX · $235.4K · around 05/27 | Whalegun